Paul Tudor Jones’s Globus Medical GMED Stock Holding History

Paul Tudor Jones’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,800	Closed	-$1.12M	–	3879
2025 Q4	$1.12M	Buy	+12,800	New	+$972K	﹤0.01%	2185
2025 Q2	–	Sell	-13,000	Closed	-$952K	–	3434
2025 Q1	$952K	Buy	+13,000	New	+$1.07M	﹤0.01%	1849
2021 Q4	–	Sell	-3,600	Closed	-$275K	–	2643
2021 Q3	$275K	Buy	+3,600	New	+$289K	﹤0.01%	2104

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's GMED Position: Q1 2026 in Review

Paul Tudor Jones sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 8,432 shares — an estimated $736K sold.

Paul Tudor Jones first reported a position in GMED in Q2 2013 and held it in 37 quarters. The position peaked at $11.9M in Q3 2024. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Paul Tudor Jones reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
Paul Tudor Jones sold 8,432 Globus Medical shares in Q1 2026, an estimated $736K.
Paul Tudor Jones first reported a position in Globus Medical in Q2 2013 and held it in 37 quarters.
Paul Tudor Jones's Globus Medical position peaked at $11.9M in Q3 2024.
605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.